title: Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy.
abstract: Haemochromatotic cardiomyopathy is the main cause of morbidity and mortality in patients with beta thalassaemia major. Once congestive heart failure develops most patients die in a few months. Congestive heart failure was reversed and echocardiographic findings were restored to normal in a 24 year old woman with beta thalassaemia who resumed treatment with chelation therapy (desferrioxamine).
authors.affiliation: Department of Cardiology, S Anna Hospital, Como, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Politi
authors.forename: M
authors.initials: M
authors.lastname: Sticca
authors.forename: M
authors.initials: M
authors.lastname: Galli
mesh_terms: D000328:Adult; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015913:Chelation Therapy; D003676:Deferoxamine / Q000627:therapeutic use*; D005260:Female; D006432:Hemochromatosis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D007501:Iron; D014463:Ultrasonography; D017086:beta-Thalassemia / Q000150:complications* / Q000000981:diagnostic imaging
chemical_list: D007501:Iron; D003676:Deferoxamine